Francois Nader

Francois Nader is a declared insider at 4 companies (board member); the most frequent names are Talaris Therapeutics, Inc., Alexion Pharmaceuticals Inc and Moderna, Inc. Over a trading history stretching from 20 May 2021 to 19 July 2022, the count stands at 8 filings.

Purchases make up the whole of the open-market record (2 purchases, €344k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant and 2 option exercises. In 2022 alone, the filings show 2 purchases and no sales.

The newest entry dates from 13 September 2022: an open-market purchase of €172k, in Talaris Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.